366 related articles for article (PubMed ID: 20597566)
21. High prevalence of chronic hepatitis B infection among injection drug users in Iran: the need to increase vaccination of adults at risk.
SeyedAlinaghi SA; Kheirandish P; Karami N; Salem S; Shirzad H; Jahani MR; SeyedAhmadian MR; Valiollahi P; Hosseini M; Mohraz M; McFarland W
Acta Med Iran; 2010; 48(1):58-60. PubMed ID: 21137671
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran.
SeyedAlinaghi S; Jam S; Mehrkhani F; Fattahi F; Sabzvari D; Kourorian Z; Jabbari H; Mohraz M
Acta Med Iran; 2011; 49(4):252-7. PubMed ID: 21713737
[TBL] [Abstract][Full Text] [Related]
23. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
Devi KhS; Singh NB; Singh HL; Singh YM
J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
[TBL] [Abstract][Full Text] [Related]
24. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
[TBL] [Abstract][Full Text] [Related]
25. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
26. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
Liu Y; Liu Y; Zou X; Chen W; Ling L
BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
[TBL] [Abstract][Full Text] [Related]
27. HIV risk behavior among injection drug users in Tehran, Iran.
Razani N; Mohraz M; Kheirandish P; Malekinejad M; Malekafzali H; Mokri A; McFarland W; Rutherford G
Addiction; 2007 Sep; 102(9):1472-82. PubMed ID: 17645427
[TBL] [Abstract][Full Text] [Related]
28. Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.
Wylie JL; Shah L; Jolly AM
BMC Public Health; 2006 Sep; 6():229. PubMed ID: 16970811
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M
Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
[TBL] [Abstract][Full Text] [Related]
30. Viral hepatitis and HIV infection among injection drug users in a central Iranian City.
Sofian M; Aghakhani A; Banifazl M; Azadmanesh K; Farazi AA; McFarland W; Eslamifar A; Ramezani A
J Addict Med; 2012 Dec; 6(4):292-6. PubMed ID: 22895463
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic.
Platt L; Vickerman P; Collumbien M; Hasan S; Lalji N; Mayhew S; Muzaffar R; Andreasen A; Hawkes S
Sex Transm Infect; 2009 Apr; 85 Suppl 2():ii17-22. PubMed ID: 19307346
[TBL] [Abstract][Full Text] [Related]
32. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
Mohsen AH; Murad S; Easterbrook PJ
HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
Imani R; Karimi A; Rouzbahani R; Rouzbahani A
East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
[TBL] [Abstract][Full Text] [Related]
35. The risk of HIV and HCV infections among injection drug users in northeast India.
Mahanta J; Borkakoty B; Das HK; Chelleng PK
AIDS Care; 2009 Nov; 21(11):1420-4. PubMed ID: 20024719
[TBL] [Abstract][Full Text] [Related]
36. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California.
Fisher DG; Reynolds GL; Jaffe A; Perez MJ
J Addict Dis; 2006; 25(2):25-32. PubMed ID: 16785216
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico.
Reyes JC; Colón HM; Robles RR; Rios E; Matos TD; Negrón J; Marrero CA; Calderón JM; Shepard E
J Urban Health; 2006 Nov; 83(6):1105-13. PubMed ID: 17075726
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients.
Bollepalli S; Mathieson K; Bay C; Hillier A; Post J; Van Thiel DH; Nadir A
Sex Transm Dis; 2007 Jun; 34(6):367-70. PubMed ID: 17016234
[TBL] [Abstract][Full Text] [Related]
40. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]